Constipation and stomach ache were reported more frequently in the active group (10%) compared to the placebo group (3%)
This research blend combines a NAD + -associated coenzyme component , a mitochondria-derived peptide , and an NNMT-pathway small-molecule analog into a single laboratory formulation for investigational use
Alhourani HM, Kumar A, George LK, Sarwar T, Wall BM
A small randomised open label pilot study authored by Vasudevan et al
The most common side effects are nausea, mild digestive discomfort, and reduced appetite, especially in the first few weeks as your dose increases
Semaglutide: Through once-weekly dosing, this long-acting GLP-1 lowers blood glucose and supports sustained weight loss